ATEC - Alphatec Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.9400
+0.2900 (+6.24%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous close4.6500
Open4.7500
Bid0.0000 x 1000
Ask0.0000 x 1100
Day's range4.6450 - 4.9800
52-week range2.1900 - 7.9300
Volume320,433
Avg. volume658,642
Market cap313.359M
Beta (5Y monthly)1.60
PE ratio (TTM)N/A
EPS (TTM)-1.3420
Earnings date11 May 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est8.88
  • Alphatec Holdings Inc (ATEC) Q1 2020 Earnings Call Transcript
    Motley Fool

    Alphatec Holdings Inc (ATEC) Q1 2020 Earnings Call Transcript

    Image source: The Motley Fool. Alphatec Holdings Inc (NASDAQ: ATEC)Q1 2020 Earnings CallMay 11, 2020, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood afternoon, everyone, and welcome to Alphatec's First Quarter 2020 Financial Results and Recent Corporate Highlights Announcement.

  • GlobeNewswire

    ATEC Reports First Quarter 2020 Financial Results and Recent Corporate Highlights

    • New Product Adoption Drives U.S. Revenue Growth of 27%• Additional $35 Million Capital Commitment Provides Runway for Continued Execution  CARLSBAD, Calif., May 11, 2020 --.

  • GlobeNewswire

    Alphatec to Report First Quarter 2020 Financial Results on May 11, 2020

    CARLSBAD, Calif., April 28, 2020 -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC” or the “Company”), a provider of innovative spine surgery solutions dedicated to.

  • GlobeNewswire

    ATEC Terminates Agreement to Acquire EOS Imaging

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today that it has terminated the Tender Offer Agreement (“TOA”), dated February 26, 2020, under which it was to acquire EOS imaging, SA (“EOS”), for up to $88 million, plus debt retirement of $33.9 million, in a combination of cash and equity. Based upon its assessment, ATEC concluded that a “Material Adverse Effect” (as defined in the TOA) has occurred, resulting in circumstances that are no longer conducive to completion of the transaction described in the TOA.

  • GlobeNewswire

    ATEC Announces Preliminary First Quarter 2020 Revenue Results And Provides Business Update

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today preliminary revenue results for the first quarter ended March 31, 2020, and provided a business update on its response to the COVID-19 pandemic. Preliminary, unaudited first quarter 2020 results reflect U.S. revenue growth of 25% to 26%.

  • Associated Press

    Alphatec: 4Q Earnings Snapshot

    CARLSBAD, Calif. (AP) _ Alphatec Holdings Inc. (ATEC) on Thursday reported a loss of $17 million in its fourth quarter. The Carlsbad, California-based company said it had a loss of 28 cents per share. The medical equipment and supplies holding company posted revenue of $32.4 million in the period.

  • GlobeNewswire

    ATEC Reports Fourth Quarter and Full Year 2019 Financial Results

    U.S. Revenue Grew Nearly 30% Year-Over-Year for the Full YearAnd 35% Year-Over-Year in the Fourth Quarter CARLSBAD, Calif., March 05, 2020 -- Alphatec Holdings, Inc. (“ATEC”.

  • GlobeNewswire

    ATEC Announces Agreement to Acquire EOS imaging 

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today that it has entered into an agreement to acquire EOS imaging, SA, for a purchase price of up to $88 million, plus debt retirement of $33.9 million, in a combination of cash and equity. EOS imaging is a leader in outcome-improving orthopedic medical imaging and software solutions, and is globally recognized for its rapid, low dose, biplanar full-body imaging and 3D modeling capabilities.

  • GlobeNewswire

    Alphatec to Report Fourth Quarter and Fiscal Year 2019 Financial Results on March 5th 2020, and Participate in Upcoming Investor Conference

    The Company will host a live webcast and audiocast of the conference on Thursday, March 5, 2020, at 1:30 p.m. PT / 4:30 p.m. ET. The live webcast will be accessible at: https://edge.media-server.com/mmc/p/cocjhkoy. An audiocast of the conference call will be available domestically at (877) 556-5251 and internationally at (720) 545-0036.

  • GlobeNewswire

    ATEC Announces Preliminary 2019 Revenue Results and 2020 Revenue Outlook

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today preliminary revenue results for the fourth quarter and full year ended December 31, 2019, and provided revenue guidance for the full year 2020.

  • GlobeNewswire

    ATEC Announces Commercial Launch of the SafeOp Neural InformatiX System™

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of the SafeOp Neural InformatiX System (“SafeOp”), which has been designed to seamlessly integrate critical neural information into ATEC procedural solutions. “Today, we are launching the first reflection of the innovation that we expect to deliver through the SafeOp platform: a powerful technology that meets an unmet need for objective, intraoperative neural information during surgery,” said Pat Miles, Chairman and Chief Executive Officer. The SafeOp Neural InformatiX System has been engineered with electromyography (EMG) and somatosensory evoked potentials (SSEP) to provide surgeons with actionable information regarding both the location and the health of nerves at risk during surgery.

  • GlobeNewswire

    ATEC to Participate in The Canaccord Genuity MedTech and Diagnostics Forum and The Piper Jaffray 31st Annual Healthcare Conference

    Jeff Black, Chief Financial Officer, will participate in one-on-one meetings at the Canaccord Genuity MedTech and Diagnostics Forum on Thursday, November 21, 2019, at The Westin Grand Central Hotel in New York City. Pat Miles, Chairman and Chief Executive Officer, will present at the Piper Jaffray 31st Annual Healthcare Conference on Wednesday, December 4th, 2019, at 3:30 p.m. E.T., at the Lotte New York Palace Hotel in New York City. A live audio webcast of the Piper Jaffray Conference presentation, along with copies of the accompanying presentation materials, will be available online from the Investor Relations page of the Company's corporate website at www.atecspine.com.

  • Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates
    Zacks

    Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates

    Alphatec (ATEC) delivered earnings and revenue surprises of 4.35% and 8.76%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press

    Alphatec: 3Q Earnings Snapshot

    CARLSBAD, Calif. (AP) _ Alphatec Holdings Inc. (ATEC) on Wednesday reported a loss of $14.6 million in its third quarter. The Carlsbad, California-based company said it had a loss of 26 cents per share. Losses, adjusted for non-recurring costs and to account for discontinued operations, were 22 cents per share.

  • GlobeNewswire

    ATEC Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

    Third Quarter U.S. Revenue Growth of 34% Year-Over-YearDrives Increase in Full Year 2019 Guidance   CARLSBAD, Calif., Oct. 30, 2019 -- Alphatec Holdings, Inc. (“ATEC” or the.

  • Analysts Estimate Alphatec (ATEC) to Report a Decline in Earnings: What to Look Out for
    Zacks

    Analysts Estimate Alphatec (ATEC) to Report a Decline in Earnings: What to Look Out for

    Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    Alphatec Enhances its Lateral Portfolio With the Commercial Launch of Approach-Specific Innovation

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of its porous titanium line of IdentiTi™ implants for lateral interbody fusion (LIF) procedures. The Company has successfully commercialized all of the six IdentiTi Implant Systems slated for release in 2019. The Company also announced the commercial release of the AMP™ Lateral Anti-Migration Plate, as well as the re-design and reconfiguration of its PEEK lateral interbody implant offering, Transcend™.

  • GlobeNewswire

    Alphatec to Report Third Quarter 2019 Financial Results on October 30, 2019

    CARLSBAD, Calif., Oct. 10, 2019 -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC” or the “Company”), a provider of innovative spine surgery solutions dedicated to.

  • GlobeNewswire

    Alphatec Announces Commercial Launch of IdentiTi™ TLIF Posterior Oblique Porous Titanium Interbody Implant System

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of its IdentiTi TLIF Posterior Oblique Titanium Interbody Implant System (“IdentiTi PO”) for transforaminal lumbar interbody fusion procedures.  The launch of IdentiTi (TLIF) PO follows successful alpha evaluations that began in January 2019 and marks the fifth of six IdentiTi Implant Systems to be launched this year by ATEC’s Organic Innovation Machine™.

  • GlobeNewswire

    Alphatec Announces Favorable Judgment in NuVasive v. Miles Lawsuit

    Alphatec Holdings, Inc. (“ATEC” or “the Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today that the Delaware Chancery Court entered summary judgment in favor of its Chairman and Chief Executive Officer, Pat Miles, terminating all non-competition and employee non-solicitation claims brought against Miles and the Company by competitor, NuVasive, Inc. (NUVA).

  • GlobeNewswire

    Alphatec to Participate in the H.C. Wainwright 21st Annual Global Investment Conference and the Lake Street Capital Markets 3rd Annual Best Ideas Growth Conference

    Jeff Black, ATEC’s Chief Financial Officer, will present at the H.C. Wainwright 21st Annual Global Investment Conference on September 10, 2019, at 4:15 P.M. ET, at the Lotte New York Palace Hotel in New York City. Pat Miles, Chairman and Chief Executive Officer, and Jeff Black will also attend Lake Street Capital Markets 3rd Annual Best Ideas Growth Conference on September 12, 2019, at the Parker New York in New York City.

  • GlobeNewswire

    Alphatec Accelerates Organic Innovation Machine™ With  Key Senior Leadership Appointment and Continued Sales Team Enhancements

    •  Eric Dasso to Lead Revolutionary Alpha InformatiX™ Platform•  Wyatt Stanfield to Drive Western US Sales Expansion CARLSBAD, Calif., Aug. 15, 2019 -- Alphatec Holdings, Inc..

  • GlobeNewswire

    Alphatec Advances InVictus™ MIS Spinal Fixation System With Commercial Launch of SingleStep™

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of InVictus Minimally Invasive, or MIS, SingleStep K-wireless implant delivery system. SingleStep utilizes an all-in-one driver designed to enhance surgical efficiency without compromising accuracy. “This release enhances the functionality and distinction of ATEC’s newly-launched InVictus platform with technology that has been engineered to profoundly improve the elegance of percutaneous fixation,” said Pat Miles, Chairman and Chief Executive Officer.  “SingleStep enables increased surgeon control of the variables surrounding percutaneous pedicle screw placement.

  • GlobeNewswire

    Alphatec Holdings, Inc. Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock

    Alphatec Holdings, Inc. (“ATEC”) (ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten public offering of 12,535,000 shares of its common stock at a public offering price of $4.60 per share, which includes the full exercise of the underwriters’ option to purchase 1,635,000 additional shares of common stock to cover over-allotments. Piper Jaffray and Canaccord Genuity acted as joint book-running managers in the offering. Lake Street Capital Markets acted as co-manager in the offering.

  • GlobeNewswire

    Alphatec to Present at the Canaccord Genuity 39th Annual Growth Conference

    Alphatec Holdings, Inc. (“ATEC” or the “Company”) (ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that it will attend the 39th Annual Growth Conference taking place at the InterContinental Hotel in Boston.  Pat Miles, Chairman and CEO, will present a business overview at the conference on August 7, 2019, at 5:00 P.M. ET. A live audio webcast of the conference presentation, along with a copy of the accompanying presentation materials, will be available online from the Investor Relations page of the Company's corporate website at www.atecspine.com. Alphatec Holdings, Inc., through its wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp Surgical, Inc., is a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery.